Search Results for: SRC

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel WAS WASP actin nucleation promoting factor
  • Generation of second messenger molecules
  • Regulation of actin dynamics for phagocytic cup formation
  • Regulation of actin dynamics for phagocytic cup formation
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate WASPs and WAVEs
  • CDC42 GTPase cycle
  • RAC1 GTPase cycle
  • RHOJ GTPase cycle
  • FCGR3A-mediated phagocytosis
  • FCGR3A-mediated phagocytosis
  • (S)-wiskostatin
  • Neutropenic disorders, including the following three diseases: Kostmann syndrome; Cyclic neutropenia; X-linked neutropenia/myelodysplasia
  • Thrombocytopenia (THC); Familial platelet disorder with associated myeloid malignancy (FPDMM)
  • Other well-defined immunodeficiency syndromes, including the following seven diseases: Wiskott-Aldrich syndrome; DiGeorge syndrome; Hyper-IgE syndrome; X-linked lymphoproliferative syndrome; Immunodeficiency, Polyendocrinopathy, Enteropathy, X-linked Syndrome (IPEX); Cartilage-Hair Hypoplasia; Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
Novel WASL WASP like actin nucleation promoting factor
  • Regulation of actin dynamics for phagocytic cup formation
  • Regulation of actin dynamics for phagocytic cup formation
  • NOSTRIN mediated eNOS trafficking
  • Nephrin family interactions
  • EPHB-mediated forward signaling
  • EPHB-mediated forward signaling
  • DCC mediated attractive signaling
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate WASPs and WAVEs
  • Clathrin-mediated endocytosis
  • CDC42 GTPase cycle
  • RAC1 GTPase cycle
  • RHOQ GTPase cycle
  • RHOJ GTPase cycle
  • RHOV GTPase cycle
  • FCGR3A-mediated phagocytosis
  • FCGR3A-mediated phagocytosis
Novel WBP11 WW domain binding protein 11
  • mRNA Splicing - Major Pathway
Novel WWOX WW domain containing oxidoreductase
  • Nuclear signaling by ERBB4
  • Negative regulation of activity of TFAP2 (AP-2) family transcription factors
  • Activation of the TFAP2 (AP-2) family of transcription factors
Novel XPA XPA, DNA damage recognition and repair factor
  • Formation of Incision Complex in GG-NER
  • Dual Incision in GG-NER
  • Formation of TC-NER Pre-Incision Complex
  • Dual incision in TC-NER
  • Disorders of nucleotide excision repair, including: Xeroderma pigmentosum (XP); Cockayne syndrome (CS); UV-sensitive syndrome (UVS); Trichothiodystrophy (TTD); Cerebro-oculo-facio-skeletal syndrome (COFS); XFE progeroid syndrome
Novel YTHDC1 YTH N6-methyladenosine RNA binding protein C1
  • Nuclear RNA decay
Novel YWHAB tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta
  • Activation of BAD and translocation to mitochondria
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • MTOR signalling
  • mTORC1-mediated signalling
  • Frs2-mediated activation
  • Frs2-mediated activation
  • ARMS-mediated activation
  • Signaling by Hippo
  • Rap1 signalling
  • Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA
  • Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
  • RHO GTPases activate PKNs
  • TP53 Regulates Metabolic Genes
  • RAF activation
  • MAP2K and MAPK activation
  • Negative regulation of MAPK pathway
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by high-kinase activity BRAF mutants
  • Signaling by BRAF and RAF1 fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
  • Regulation of localization of FOXO transcription factors
  • Signaling downstream of RAS mutants
  • Signaling by RAF1 mutants
  • SHOC2 M1731 mutant abolishes MRAS complex function
  • Gain-of-function MRAS complexes activate RAF signaling
  • SARS-CoV-1 targets host intracellular signalling and regulatory pathways
  • SARS-CoV-2 targets host intracellular signalling and regulatory pathways
  • Transcriptional and post-translational regulation of MITF-M expression and activity
  • Copper
  • Phenethyl Isothiocyanate
Novel YWHAE tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon
  • Activation of BAD and translocation to mitochondria
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Signaling by Hippo
  • NADE modulates death signalling
  • Regulation of PLK1 Activity at G2/M Transition
  • Regulation of HSF1-mediated heat shock response
  • HSF1 activation
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • RHO GTPases activate PKNs
  • TP53 Regulates Metabolic Genes
  • Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
  • AURKA Activation by TPX2
  • Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
  • RAB GEFs exchange GTP for GDP on RABs
  • SARS-CoV-1 targets host intracellular signalling and regulatory pathways
  • SARS-CoV-2 targets host intracellular signalling and regulatory pathways
  • Transcriptional and post-translational regulation of MITF-M expression and activity
  • Fusicoccin
  • Phenethyl Isothiocyanate
  • Lissencephaly (LIS); Miller-Dieker syndrome (MDLS)
Novel YWHAG tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma
  • Activation of BAD and translocation to mitochondria
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Regulation of PLK1 Activity at G2/M Transition
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • RHO GTPases activate PKNs
  • TP53 Regulates Metabolic Genes
  • Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
  • AURKA Activation by TPX2
  • Regulation of localization of FOXO transcription factors
  • SARS-CoV-1 targets host intracellular signalling and regulatory pathways
  • SARS-CoV-2 targets host intracellular signalling and regulatory pathways
  • Transcriptional and post-translational regulation of MITF-M expression and activity
  • SPOP-mediated proteasomal degradation of PD-L1(CD274)
Novel YWHAH tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta
  • Activation of BAD and translocation to mitochondria
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • RHO GTPases activate PKNs
  • TP53 Regulates Metabolic Genes
  • Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
  • SARS-CoV-1 targets host intracellular signalling and regulatory pathways
  • SARS-CoV-2 targets host intracellular signalling and regulatory pathways
  • Transcriptional and post-translational regulation of MITF-M expression and activity
  • Phenethyl Isothiocyanate
Novel ZNF189 zinc finger protein 189
  • Generic Transcription Pathway
Novel ZNF687 zinc finger protein 687
ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase
  • Regulation of actin dynamics for phagocytic cup formation
  • Role of ABL in ROBO-SLIT signaling
  • Role of ABL in ROBO-SLIT signaling
  • Myogenesis
  • Myogenesis
  • RHO GTPases Activate WASPs and WAVEs
  • HDR through Single Strand Annealing (SSA)
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Cyclin D associated events in G1
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • RUNX2 regulates osteoblast differentiation
  • FCGR3A-mediated phagocytosis
  • Factors involved in megakaryocyte development and platelet production
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
  • ATP
  • Imatinib
  • Dasatinib
  • N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide
  • Nilotinib
  • XL228
  • Bosutinib
  • 2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE
  • 1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA
  • Myristic acid
  • PD-166326
  • 5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE
  • 2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide
  • Regorafenib
  • Ponatinib
  • Fostamatinib
  • Brigatinib
  • Radotinib
  • Asciminib
  • Umbralisib
  • Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia)
  • Chronic myeloid leukemia (CML)
ACTN1 actinin alpha 1
  • Platelet degranulation
  • Syndecan interactions
  • Nephrin family interactions
  • Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
  • RHOD GTPase cycle
  • RHOBTB2 GTPase cycle
  • RHOF GTPase cycle
  • Human calcitonin
  • Copper
ADAM12 ADAM metallopeptidase domain 12
  • Signaling by EGFR
  • Invadopodia formation
ADAM15 ADAM metallopeptidase domain 15
  • Degradation of the extracellular matrix
  • Invadopodia formation
ADRB2 adrenoceptor beta 2
  • Adrenoceptors
  • G alpha (s) signalling events
  • Ub-specific processing proteases
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • Spermine
  • Amphetamine
  • Betaxolol
  • Bethanidine
  • Isoetharine
  • Cabergoline
  • Metoprolol
  • Metoprolol
  • Olanzapine
  • Atenolol
  • Norepinephrine
  • Timolol
  • Phenylpropanolamine
  • Dipivefrin
  • Sotalol
  • Carteolol
  • Nortriptyline
  • Propranolol
  • Labetalol
  • Bisoprolol
  • Epinephrine
  • Paroxetine
  • Trimipramine
  • Cryptenamine
  • Orciprenaline
  • Dobutamine
  • Pseudoephedrine
  • Alprenolol
  • Ritodrine
  • Ritodrine
  • Terbutaline
  • Bitolterol
  • Phenoxybenzamine
  • Salmeterol
  • Pindolol
  • Formoterol
  • Salbutamol
  • Ergoloid mesylate
  • Isoprenaline
  • Arbutamine
  • Amiodarone
  • Carvedilol
  • Desipramine
  • Propafenone
  • Acebutolol
  • Nadolol
  • Levobunolol
  • Metipranolol
  • Aripiprazole
  • Arformoterol
  • Fenoterol
  • Pirbuterol
  • Bevantolol
  • Penbutolol
  • Ephedra sinica root
  • Ephedrine
  • Mephentermine
  • Procaterol
  • Clenbuterol
  • Bambuterol
  • Oxprenolol
  • Putrescine
  • Spermidine
  • Celiprolol
  • Nebivolol
  • Indacaterol
  • Bedoradrine
  • NCX 950
  • Asenapine
  • Droxidopa
  • Bufuralol
  • Protokylol
  • (S)-carazolol
  • Bopindolol
  • Bupranolol
  • Befunolol
  • Olodaterol
  • Vilanterol
  • Viloxazine
  • Arotinolol
  • Doxofylline
  • Racepinephrine
  • Dihydroergocornine
  • DL-Methylephedrine
  • Etafedrine
  • Tulobuterol
  • Levosalbutamol
  • Dihydroergocristine
  • Methoxyphenamine
  • Asthma
ADRB3 adrenoceptor beta 3
  • Adrenoceptors
  • G alpha (s) signalling events
  • Amphetamine
  • Bethanidine
  • Metoprolol
  • Dihydroergotamine
  • Olanzapine
  • Norepinephrine
  • Nortriptyline
  • Propranolol
  • Paroxetine
  • Trimipramine
  • Cryptenamine
  • Alprenolol
  • Ritodrine
  • Terbutaline
  • Salmeterol
  • Pindolol
  • Formoterol
  • Salbutamol
  • Ergoloid mesylate
  • Isoprenaline
  • Arbutamine
  • Amiodarone
  • Fenoterol
  • Ephedra sinica root
  • Mephentermine
  • Clenbuterol
  • Oxprenolol
  • Celiprolol
  • Nebivolol
  • Amibegron
  • Solabegron
  • Droxidopa
  • Bufuralol
  • Bopindolol
  • Bupranolol
  • Mirabegron
  • Racepinephrine
  • Dihydroergocornine
  • DL-Methylephedrine
  • Dihydroergocristine
  • Vibegron
AFAP1 actin filament associated protein 1
AFAP1L2 actin filament associated protein 1 like 2

Page 16 out of 32 pages